curriculum vitae daniel finkelstein, m.d.€¦ · curriculum vitae daniel finkelstein, m.d....

CURRICULUM VITAE

DANIEL FINKELSTEIN, M.D.

ADDRESSES: HOME: 1907 South Road, Baltimore, MD 21209

(410) 466-0285

OFFICE: The Wilmer Institute

The Johns Hopkins Hospital

600 N. Wolfe Street

Room 729 Maumenee Building

Baltimore, MD 21287-9227

Phone: (410) 955-3429

FAX: (410) 955-0868

E-mail: [email protected]

BIRTHPLACE & DATE: April 13, 1940, Philadelphia, PA

EDUCATION: College: Harvard College 1958-62

Medical School: University of PA 1962-67

Post-Sophomore Fellowship:

Free University of Berlin

Electrophysiology 1964-65

Postgraduate – MA Theology 2008

St. Mary’s Seminary & University

Ecumenical Institute

INTERNSHIP: Pennsylvania Hospital, Philadelphia, PA 1967-68

MILITARY: National Eye Institute

Staff Associate

Public Health Service 1968-70

RESIDENCY: The Wilmer Institute 1970-73

Chief Resident, The Wilmer Institute 1974-75

FELLOWSHIP: The Wilmer Institute

Experimental Retinal Neovascularization 1973-74

PRESENT POSITION: Professor of Ophthalmology

The Wilmer Institute

The Johns Hopkins University Sch. Med. 1993-present

Core Faculty 1995-present

Johns Hopkins Berman Institute of Bioethics

Faculty

Johns Hopkins Mind Body Institute

Daniel Finkelstein, M.D.

2

Faculty

The Bioethics Institute 1995-present

The John Hopkins University Sch. Med.

LICENSURE: State of Maryland

Diplomat, National Board of Medicine

Examiners

Board Certified, Ophthalmology

RESEARCH INTERESTS: Retinal Vascular Disease

Retinal Degenerative Disease

Medical Ethics

NATIONAL POSITIONS:

Editorial Board, American Academy of Ophthalmology

“Focal Points” series 1988-1993

Editorial Board, Retina, 1980-1990

Editorial Board, Current Eye Research, 1993-1996

Deputy Chairman, Nationwide Collaborative

Central Vein Occlusion Study, 1987-1994

Chairman, Executive Committee, National Collaborative

Branch Vein Occlusion Randomized Clinical Trial, 1976-1986

Chairman, ARVO, Retina Section, 1981

Consultant, National Diabetes Advisory Board

Ocular Complication, October, 1979

Study Section, NIH, 1981-1984

Chairman, NIH Study Section, Visual Disorders, 1984

Co-Chairman, NIH Diabetes Coordinating Committee

Task Force on Animal Models, Ocular Complications

Chairman, Data and Safety Monitoring Board

Krypton-Argon Regression of Neovascularization

Multi-Center Randomized Clinical Trial, 1987


3

Director, Skills Transfer Course, Vein Occlusion

American Academy of Ophthalmology, 1992-1997

Macula Society, Program Chairman, 1987-1990

Macula Society, Credentials Chairman, 1995-1998

Macula Society, Treasurer, 1998-2000

Macula Society, Secretary, 2000-2002

Macula Society, President-elect, 2002-2004

Macula Society, President 2004-2006

Sub-section Editorial Consultant, Medical Ethics

Archives of Ophthalmology, 1992-1994

Data and Safety Monitoring Board, Silicone Study

Multi-Center Randomized Clinical Trial, 1986

Retinal Disease Committee, National Society to Prevent

Blindness, 1986

Publication Review Board, Early Treatment Diabetic Study

Multi-Center Randomized Clinical Trial, 1986-1991

Member - Task Force on Alternative Therapies

American Academy of Ophthalmology, Jan. 1, 2000

JOHNS HOPKINS POSITIONS:

Joint Committee on Clinical Investigation (IRB) 1986-2001

Medical Ethics Committee, 1987 through 1998

Chairman, Medical Ethics Committee, 1997 through 1998

Editor, Medical Ethics Newsletter, 1991 through 1998

Palliative Care Steering Committee, 1998

Laser Committee, 1985

Medical Committee for Performing Artists, 1987

Clinical Research Center Committee


4

WILMER POSITIONS:

Review of all human research projects for JCCI (IRB), 1986-2001

Wilmer Library Committee, 1975-1990

Wilmer Memorial Committee

GRANTS:

Principal Investigator:

Bioethics, Patient-Physician Trust Relationship, 2002-2003

Bioethics, Progressive Vision Loss, 2002-2002

Diabetes Research and Wellness Foundation

Grant for Diabetic Retinopathy Screening, 1994-present

HSCRC Grant for Diabetic Retinopathy Screening, 1993-1996

Central Vein Occlusion Study, Participating Center, NEI, 1988-

1994

Multi-Center BVOS: Macular Edema Data Analysis, NEI

EY06142, 1986-1989

Branch Vein Occlusion Study, Coordinating Center, NEI,

EY02466

National Director of Multi-University Clinical Trial, 1976-1986

Branch Vein Occlusion Study, Participating Center, NEI,

EY02469, 1976-1986

Studies in Retinitis Pigmentosa, NEI, EY01791, 1976-1994

Retinitis Pigmentosa

Retinitis Pigmentosa Foundation, 1977-1980

Experimental Retinal Neovascularization, NEI, EY01368, 1975-

1978


5

Consultant:

Early Treatment Diabetic Retinopathy Study

Juvenile Diabetic Retinopathy Study

Studies of Visual Function in Retinal Ischemia

Retinal Function Changes Accompanying Age-Related Drusen

Blindness and Visual Impairment Among Mexican Hispanics

Program Coordinator:

Wilmer Core Grant, NEI, EY01765


6

PUBLICATIONS:

1. Finkelstein, D., Grusser, O.J.: Frog retina: Detection of movement. Science, 1050-1053,

1965.

2. Finkelstein, D., Grusser, O.J., Reich-Motel, H.: Reaktionen einzelner retinaneurone des

frosches (rana esculenta) auf bewegte reize verschiedener winkelgeschwindigkeit.

Pflugers Archiv fur die gesamte Physiologie, 283: R48-49, 1965.

3. Grusser, O.J., Finkelstein, D.: Analyses eines auf “bewegungswahrnehmung:”

spezialisierten neuronensytems in der froschnetzhut. In der Kybernetik: R. Oldenbourg,

Verlag, Munchen Wien, 1967.

4. Grusser, O.J., Grusser-Cornehls, U., Finkelstein, D., Henn, V., Patutschnik, M.,

Butenandt, E.: A quantitative analysis of movement detecting neurons of the frog’s

retina. Pflugers Archiv fur die gesamte Physiologie, 293: 100-106, 1967.

5. Finkelstein, D., Gouras, P., Hoff, M.: Human electroretinogram near the absolute

threshold of vision. Invest. Ophthalmol. Vis. Sci., 7: 214-218, 1968.

6. Grusser, O.J., Finkelstein, D., Grusser-Cornehls, U.: The effect of stimulus velocity on

the response of movement sensitive neurons of the frog’s retina. Pflugers Archiv, 300:

49-66, 1968.

7. Finkelstein, D., Gouras, P.: Visual electrophysiology: an introduction to ERG, EOG,

ERP, and VER. Int. Ophthalmol. Clin., 9(4): 857-881, 1969.

8. Finkelstein, D., Gouras, P.: Human electroretinogram near the absolute threshold of

vision. Int. Ophthalmol. Clin., 9(4): 1073-1081, 1969.

9. Einaguler, R.B., Finkelstein, D., Gunkel, R.D., Brown, C.H., Collins, E.A.: Retinitis

pigmentosa and lymphocytic leukemia. Arch. Ophthalmol., 85: 699-702, 1971.

10. Diabetic Retinopathy Study Research Group: Preliminary report on the effects of

photocoagulation therapy. Am. J. Ophthalmol., 81: 383-396, 1976.

11. Brem, S., Brem, H., Folkman, J., Finkelstein, D., Patz, A.: Prolonged tumor dormancy by

prevention of neovascularization in the vitreous. Cancer Res., 36: 2807-2812, 1976.

12. Fine, S., Patz, A., Orth, D., Klein, M., Finkelstein, D., Yassur, Y.: Subretinal

neovascularization developing after prophylactic argon laser photocoagulation of atrophic

“histo spots.” Am. J. Ophthalmol., 82: 352-357, 1976.

13. Radius, R., Finkelstein, D.: Central retinal artery occlusion (reversible) in sickle trait with

glaucoma. Br. J. Ophthalmol., 60: 428-430, 1976.


7

14. Charache, S., Finkelstein, D., Lietman, P., Scott, J.: Peripheral and optic neuritis in a

patient with hemoglobin SC disease during treatment of salmonella osteomyelitis with

chloramphenicol. The Johns Hopkins Medical Journal, 140: 121-124, 1977.

15. Finkelstein, D., Brem, S., Patz, A., Folkman, J., Miller, S., Chen, C.: Experimental retinal

neovascularization induced by intravitreal tumors. Am. J. Ophthalmol., 83: 660-664,

1977.

16. Patz, A., Fine, S., Finkelstein, D., Yassur, Y.: Diseases of the macula: diagnosis and

management of choroidal neovascularization. Trans. Am. Acad. Ophthalmol. &

Otolaryngol., 83: 468-472, 1977.

17. Patz, A., Yassur, Y., Fine, S., Finkelstein, D., Orth, D.: Branch retinal venous occlusion.

Trans. Am. Acad. Ophthalmol. & Otolaryngol., 83: 373-378, 1977.

18. Finkelstein, D.: Macular edema. Int. Ophthalmol. Clin., 17: 113-120, 1977.

19. The Diabetic Retinopathy Study Research Group: Photocoagulation treatment of

proliferative diabetic retinopathy: the second report of diabetic retinopathy study

findings. Trans. Am. Acad. Ophthalmol. & Otolaryngol., 85: 82-106, 1978.

20. Patz, A., Brem, S., Finkelstein, D., Chen, C.H., Lutty, G., Bennett, A., Coughlin, W.R.,

Gardner, J.: A new approach to the problem of retinal neovascularization. Trans. Am.

Acad. Ophthalmol. & Otolaryngol., 85: 626-637, 1978.

21. The Diabetic Retinopathy Study Research Group: Four risk factors for severe visual loss

in diabetic retinopathy: the third report from the diabetic retinopathy study. Arch.

Ophthalmol., 97: 654-655, 1979.

22. Massof, R.W., Finkelstein, D., Starr, S., Kenyon, K.R., Fleischman, F.A., Maumenee,

I.H.: Bilateral symmetry of vision disorders in typical retinitis pigmentosa. Br. J.

Ophthalmol., 63: 90-96, 1979.

23. Massof, R.W., Finkelstein, D.: Rod sensitivity relative to cone sensitivity in retinitis

pigmentosa. Invest. Ophthalmol. & Vis. Sci., 18: 263-272, 1979.

24. Massof, R.W., Finkelstein, D.: Vision threshold profiles in x-linked retinitis pigmentosa.

Invest. Ophthalmol. & Vis. Sci., 18: 426-429, 1979.

25. Massof, R.W., Finkelstein, D.: Vision threshold profiles in sector retinitis pigmentosa.

Arch. Ophthalmol., 97: 1899-1904, 1979.

26. Report of the National Advisory Eye Council. Vision research: a national plan. 1978-

1982. HEW Publ. 78-1258.


8

27. National Diabetes Advisory Board: Report of national conference on diabetes: current

status and future directions. Appendix to the third Annual Report of the National

Diabetes Advisory Board, NIH publ. 80-2073, 1980.

28. Finkelstein, D.: Diabetic retinopathy. Postgraduate Course in Internal Medicine. The

Johns Hopkins School of Medicine, vol. VI, Program 6:17, 1980.

29. Massof, R.W., Finkelstein, D.: Subclassification of retinitis pigmentosa from two color

scotopic static perimetry. Documenta Ophthalmologica Proceedings Series, Greve, E.L.

and Verriest, G., eds., 26: 219-225, 1981.

30. Finkelstein, D., Patz, A., Fine, S.L., Rice, T.A., Murphy, R.P.: Diabetic foveal abortive

retinal neovascularization. Retina, 1: 62-66, 1981.

31. Massof, R.W., Johnson, M.A., Finkelstein, D.: Peripheral absolute threshold spectral

sensitivity in retinitis pigmentosa. Br. J. Ophthalmol., 65: 112-121, 1981.

32. Engerman, R., Finkelstein, D., Aguirre, G., Diddie, K.R., Fox, R.R., Frank, R.N., Varma,

S.D.: Ocular complications. Diabetes, 31: 82-88, 1982.

33. Massof, R.W., Finkelstein, D.: Two forms of autosomal dominant primary retinitis

pigmentosa. Documenta Ophthalmologica, 51: 289-346, 1981.

34. Frangieh, G.T., Green, W.R., Barraquer-Somers, E., Finkelstein, D.: Histopathologic

study of nine branch retinal vein occlusions. Arch. Ophthalmol., 100: 1132-1140, 1982.

35. Finkelstein, D., Reissig, M., Kashima, H., Massof, R., Hillis, A., Proctor, A.: Nasal cilia

in retinitis pigmentosa. Birth Defects: Original article series, 18: 197-206, 1982.

36. Massof, R., Finkelstein, D., Boughman, J.: Genetic analysis of subgroups within simplex

and multiplex retinitis pigmentosa. Birth Defects: Original article series, 18: 161-166,

1982.

37. Sternberg, P., Knox, D., Finkelstein, D., Green, R.W., Murphy, R.P., Patz, A.: Acute

retinal necrosis syndrome. Retina, 2: 145-151, 1982.

38. Finkelstein, D., Clarkson, J., Diddie, K., Hillis, A., Kimball, A., Orth, D., Trempe, C.,

Branch Vein Occlusion Study Group: Branch vein occlusion: retinal neovascularization

outside the involved segment. Ophthalmol., 89: 1357-1361, 1982.

39. Sternberg, P., Fitzke, F., Finkelstein, D.: Cyclic macular edema. Am. J. Ophthalmol., 94:

664-669, 1982.

40. DeBustros, S., Miller, N.R., Finkelstein, D., Massof, R.: Bilateral astrocytic hamartomas

of the optic nerve head in retinitis pigmentosa. Retina, 3: 21-23, 1983.


9

41. Branch Vein Occlusion Study Group: Branch vein occlusion study. Ophthalmic Forum.

1: 56, 1983.

42. Cohen, S.M.Z., Fine, S.L., Murphy, R.P., Finkelstein, D., Patz, A.: Transient delay in

segmental choroidal filling after krypton red laser photocoagulation for choroidal

neovascular membranes. Retina, 3: 284-290, 1983.

43. Massof, R.W., Wu, L., Finkelstein, D., Perry, C., Starr, S.J., Johnson, M.A.: Properties of

electroretinographic intensity response functions in retinitis pigmentosa. Documenta

Ophthalmologica, 57: 279-296, 1984.

44. Branch Vein Occlusion Study Group: Argon laser photocoagulation for macular edema in

branch vein occlusion. Am. J. Ophthalmol., 98: 271-282, 1984.

45. Fine, S.L., Murphy, R.P., Finkelstein, D., Patz, A.: Membership Benefit Module 1: Age-

related macular degeneration. Am. Acad. Ophthalmol. Focal Points, Clinical Modules

for Ophthalmologists, 1984.

46. Finkelstein, D.: The management of macular degeneration in the aging eye. Sightsaving

(National Society to Prevent Blindness), 1984-85; 53(4): 8-9.

47. Sunness, J.S., Massof, R.W., Johnson, M.A., Finkelstein, D., Fine, S.L.: Peripheral retinal

function in age-related macular degeneration. Arch. Ophthalmol., 103: 811-816, 1985.

48. Lang, G.K., Surer, J.L., Green, W.R., Finkelstein, D., Michels, R.G., Maumenee, A.E.:

Ocular reticulum cell sarcoma: clinicopathologic correlation of a case with multifocal

lesions. Retina, 5: 79-86, 1985.

49. Little, H.L.: Nonproliferative diabetic retinopathy. Am. Acad. Ophthalmol., Vol. III,

Module 11: 1-11, 1985. Finkelstein, D. Consultant.

50. Branch Vein Occlusion Study Group: Argon laser scatter photocoagulation for prevention

of neovascularization and vitreous hemorrhage in branch vein occlusion: a randomized

clinical trial. Arch. Ophthalmol., 104: 34-41, 1986.

51. Massof, R.W., Johnson, M.A., Sunness, J.S., Perry, C., Finkelstein, D.: Flicker

electroretinogram in retinitis pigmentosa. Document Ophthalmol., 61: 231-245, 1986.

52. Finkelstein, D.: Argon laser photocoagulation for macular edema in branch vein

occlusion. Ophthalmol., 93: 975-977, 1986.

53. El Baba, F., Green, W.R., Fleischman, J., Finkelstein, D., De la Cruz, C.Z.:

Clinicopathologic correlation of lipidization and detachment of the retinal pigment

epithelium. Am. J. Ophthalmol., 101: 576-583, 1986.


10

54. Patz, A., Finkelstein, D., Fine, S.T., Murphy, R.P.: The role of fluorescein angiography in

national collaborative studies. Ophthalmol., 93: 1466-1470, 1986.

55. Finkelstein, D., Patz, A.: Changes in the retinal pigment epithelium associated with

cystoid macular edema. Tr. Am. Ophthalmol. Soc., 84: 293-303, 1986.

56. Finkelstein, D.: Current techniques: Branch retinal vein occlusion. Ophthalmol. Laser

Therapy, 2: 121, 1987.

57. Bowers, D.K., Finkelstein, D., Wolff, S.M., Green, W.R.: Branch retinal vein occlusion.

A clinicopathologic case report. Retina, 7: 252-259, 1987.

58. Finkelstein, D., Clarkson, J., and the Branch Vein Occlusion Study Group: Branch and

central retinal vein occlusions. Focal Points, Vol. V, Module 12, 1987.

59. Wilson, D.J., Finkelstein, D., Quigley, H.A., Green, W.R.: Macular grid

photocoagulation: An experimental study on the primate retina. Arch. Ophthalmol., 106:

100-105, 1988.

60. Finkelstein, D.: The treatment of BVO: Who, how and why? Video J. Ophthalmol., Vol.

IV, #2, April, 1988.

61. Finkelstein, D., Patz, A.: Distant effect of peripheral branch vein occlusion on the

macula. Tr. Am. Ophthalmol. Soc., Vol. LXXXVI 380-388, 1988.

62. Finkelstein, D.: Central retinal vein occlusion: The state of the art. Video J. Ophthalmol.,

Vol. V, #2, April, 1989.

63. Klein, M.L., Finkelstein, D.: Macular grid photocoagulation for macular edema in central

retinal vein occlusion. Arch. Ophthalmol., 107: 1297-1302, 1989.

64. Madreperla, S.A., Palmer, R.W., Massof, R.W., Finkelstein, D.: Visual acuity loss in

retinitis pigmentosa: A relationship to the visual field. Arch. Ophthalmol., 108: 358-361,

1990.

65. Finkelstein, D.: Laser treatment of branch and central retinal vein occlusions. Int.

Ophthalmol. Clinics, Vol. 30, No. 2, Spring, 1990.

66. Bressler, N., Finkelstein, D., Sunness, J., Maguire, A., Yarian, D.: Retinal pigment

epithelial tears through the fovea with preservation of good visual acuity. Arch.

Ophthalmol., 108: 1694-1697, 1990.

67. Massof, R.W., Dagnelie, G., Benzschawel, T., Palmer, R.W., Finkelstein, D.: First order

dynamics of visual field loss in retinitis pigmentosa. Clin. Vis. Sci., 5: 1-26, 1990.


11

68. Finkelstein, D., Feinberg, S.J., Flom, R.E., Hedstrom, N.J., Leinhaas, M., Raasch, T.W.,

Rubin, G.S., Massof, R.W.: Visual prostheses and visual rehabilitation in low vision

research, assessment and management. Curr. Opinion in Ophthalmol., 2: 729-732, 1991.

69. Finkelstein, D.: Ischemic macular edema: Recognition and favorable natural history in

branch vein occlusion. Arch. Ophthalmol., 110: 1427-1434, 1992.

70. Holroyd, S., Rabins, P.V., Finkelstein, D., Nicholson, M.C., Chase, G.A., Wisniewski,

S.C.: Visual hallucinations in patients with macular degeneration. Amer. J. Psychiatry,

149:12, 1992.

71. Finkelstein, D., Smith, M.K., Faden, R.: Informed consent and medical ethics. Arch

Ophthalmol., 111: 324-326, 1993.

72. Central Vein Occlusion Study Group: Baseline and early natural history report. The

Central vein occlusion study. Arch. Ophthalmol., 111: 1087-1095, 1993.

73. The Krypton Argon Regression Neovascularization Study Research Group: Randomized

comparison of Krypton versus argon scatter photocoagulation for diabetic disc

neovascularization. Ophthalmol., 100: 1655-1664, 1993.

74. Finkelstein, D.: Laser treatment of macular edema resulting from branch vein occlusion.

Seminars in Ophthalmol., 9: 23-28, 1994.

75. Finkelstein, D.: Laser management of branch and central retinal vein occlusion. Chapter

8, Current Techniques in Ophthalmic Laser Surgery, Curr. Med., 86-91, 1994.

76. Holroyd, S., Rabins, P.V., Finkelstein, D., Lavrisha, M.: Visual hallucinations in patients

from an ophthalmology clinic and medical clinic population. J. Nerv. & Mental Dis.,

182: 273-276, 1994.

77. The Central Vein Occlusion Study Group M Report: Evaluation of grid pattern

photocoagulation for macular edema in central vein occlusion. Ophthalmol., 102: 1425-

1433, 1995.

78. The Central Vein Occlusion Study Group N Report: A randomized clinical trial of early

panretinal photocoagulation for ischemic central vein occlusion. Ophthalmol., 102:

1434-1444, 1995.

79. Kempster, R.C., Green, W.R., Finkelstein, D.: Choroidal rupture - Clinicopathologic

correlation of an unusual case. Retina, 16: 57-63, 1996.

80. Dunn, J.P., Noorily, S.W., Petri, M., Finkelstein, D., Rosenbaum, J.T., Jabs, D.A.:

Antiphospholipid antibodies and retinal vascular disease. Lupus, 5: 313-322, 1996.


12

81. Finkelstein, D.: Laser therapy for central retinal vein obstruction. Curr. Opinion in

Ophthalmol., 7: 80-83, 1996.

82. The Central Vein Occlusion Study Group: Natural history and clinical management of

central retinal vein occlusion. Arch. Ophthalmol., 115:486-491, 1997.

83. Finkelstein, D., Clarkson, J.G., Hillis, A.: Branch and central vein occlusion. Focal

Points. Am. Acad. Ophthalmol., vol. XV, 1-13, 1997.

84. Fekrat, S., Finkelstein, D.: Current concepts in the management of central retinal vein

occlusion. Curr. Opinion in Ophthalmol., 8;111: 50-54, 1997.

85. Finkelstein, D., Wu, A.W., Holtzman, N.A., Smith, M.E.: When a physician harms a

patient by a medical error: Ethical, legal, and risk-management considerations. The J. of

Clin. Ethics, 8: 330-335, 1997.

86. Fekrat, S., Goldberg, M.F., Finkelstein, D.: Laser-induced chorioretinal venous

anastomosis for perfused central retinal vein occlusion. Wilmer Retina Update, 3(2): 23-

27, 1997.

87. Fekrat, S., Goldberg, M.F., Finkelstein, D.: Laser-induced chorioretinal venous

anastomosis for nonischemic central or branch retinal vein occlusion. Arch.

Ophthalmol., 116: 43-52, 1998.

88. Agard, E., Finkelstein, D., Wallach, E.: Cultural diversity and informed consent. The J.

Clin. Ethics, 9: 173-176, 1998.

89. Fekrat, S., Goldberg, M.F., Finkelstein, D.: Anastomosis venosa coriorretiniana inducida

por laser para la oclusion venosa central o de rama no isquemica. Arch. Ophthalmol.,

(Edicion Espanola) 9: 127-137, 1998.

90. Cooney, M.J., Fekrat, S., Finkelstein, D.: Current concepts in the management of central

retinal vein occlusion. Curr. Opinion in Ophthalmol., 9: 47-50, 1998.

91. Duh, E.J., Finkelstein, D., Schneider, T., Malouf, A., Kaplan, G.: Bilateral iris

neovascularization as the initial sign of obesity-hypoventilation (Pickwickian) syndrome:

Hypoxia/hypercapnia as a stimulus for angiogenesis. Arch. Ophthalmol., 118: 1298-

1300, 2000.

92. Finkelstein, D.: The utility of ranking ophthalmology centers. The ranking of

ophthalmology centers in ophthalmology and lay publications is not appropriate for

medicine in today’s business world. Arch. Ophthalmol., 118: 1579-1580, 2000.

93. Hayeems, R.Z., Geller, G., Finkelstein, D., Faden, R.R.: How patients experience

progressive loss of visual function: A model of adjustment. Brit. J. Ophthalmol., British

Journal of Ophthalmology 2005; 89:615-620.


13

94. Chang, M, and Finkelstein, D.: Modified laser-induced chorioretinal anastomosis for

treatment of long-standing perfused central retinal vein occlusion (CRVO). Retina.

September 2006; 26(7):824-825.

95. The PKC-DRS Study Group*: The Effect of Ruboxistaurin on Visual Loss in Patients

With Moderately Severe to Very Severe Nonproliferative Diabetic Retinopathy.

Diabetes, 2005; 54:2188-2197.

96. The PKC-DMES Study Group*: Effect of Ruboxistaurin in Patients With Diabetic

Macular Edema. Arch. Ophthalmol., 2007; 125: 318-324.

97. Committee for the Diabetic Retinopathy Clinical Research Network: Comparison of the

Modified Early Treatment Diabetic Retinopathy Study and Mild Macular Grid Laser

Photocoagulation Strategies for Diabetic Macular Edema. Arch. Ophthalmol., 2007; 125:

469-480.

98. Magyar-Russell G, Fosarelli P, Taylor H, Finkelstein D. Ophthalmology Patients’

Religious and Spiritual Beliefs: An Opportunity to Build Trust in the Patient-Physician

Relationship. Arch Ophthalmol. 2008; 126(9):1262-1265.

99. Finkelstein D: Blind Faith. Narrative Inquiry in Bioethics, Vol. 4, No. 3, winter 2014;

199-200.


14

BOOK CHAPTERS

1. Patz, A., Finkelstein, D., Payne, J.: Fluorescein angiography in retrolental fibroplasia. In:

(Documenta Ophthalmol. Proceedings Series:9). The Hague, Dr. W. Junk bv Publishers,

9: 599-604, 1976.

2. Finkelstein, D., Patz, A.: Experimental retinal neovascularization. In: The Blood-retinal

Barriers. J.G. Cunha-Vaz (ed.), New York and London.

3. Finkelstein, D., Reissig, M., Kashima, H., Massof, R.W., Hillis, A., Proctor, A.:

Ultrastructural abnormalities in nasal cilia of retinitis pigmentosa patients. In: Genetic

Eye Diseases. E. Cottie, I. Maumenee, and E. Berman (eds.), Alan R. Liss, 197-205,

1982.

4. Finkelstein, D., Patz, A., Fine, S.L., Rice, T.A.: Retinal branch vein occlusion study. In:

Management of Retinal Vascular and Macular Disorders. S.L. Fine and S.L.Owens

(eds.), Baltimore, Williams and Wilkins, 1-4, 1983.

5. Finkelstein, D., Massof, R.W.: Status of the Wilmer Institute Retinitis Pigmentosa

Center. In: Management of Retinal Vascular and Macular Disorders. S.L. Fine and S.L.

Owens (eds.), Baltimore, Williams and Wilkins, 73-77, 1983.

6. Massof, R.W., Finkelstein, D.: A two stage hypothesis for the natural course of retinitis

pigmentosa. In: Research in Retinitis Pigmentosa. E. Zrenner, H. Kastel, H.H. Goebels

(eds.), Adv. Biosci., 62: 29-58, 1987.

7. Finkelstein, D.: Ushers syndrome. In: Medical Diagnosis in Ushers Syndrome. Charles

c. Thomas, 1988.

8. Finkelstein, D.: Branch vein occlusion. In: Medical Retina, Vol. II, chapter 75. Ryan et

al. (eds.), Mosby, 427-432, 1988.

9. Duncan, E., Prickett, H.T., Finkelstein, D., McCay, V., Hollingsworth, T.: Usher’s

syndrome. What it is, how to cope, and how to help. Charles C. Thomas, 1988.

10. Finkelstein, D.: Retinal branch vein occlusion. In: Laser Photocoagulation of the Macula.

L.A. Yannuzzi (ed.), 83-89, 1989.

11. Finkelstein, D.: Branch and central retinal vein occlusion. In: Practical Atlas of Retinal

Disease and Therapy. W.R. Freeman (ed.), Raven Press, New York, 1993.

12. Fekrat, S., Finkelstein, D.: The central vein occlusion study (CVOS). In: Clinical Trials

in Ophthalmology: A Summary and Practice Guide, chapter 8. P.J. Kertes and M.D.

Conway (eds.), Williams and Wilkins, 129-144, 1998.


15

13. Zegarra, H., Finkelstein, D., Singerman, L.J., Niffenegger, J.H., Prendergast, S.D.: Laser

management of branch and central retinal vein occlusions. In: Current Techniques in

Ophthalmic Laser Surgery, 3rd ed. L.J. Singerman and G. Coscas (eds.), Butterworth

Heinemann, 67-76, 1999.

14. Finkelstein, D.: Branch retinal vein occlusion. In: Retina-Vitreous-Macula, chapter 25.

D.R. Guyer, L.A. Yannuzzi, S. Chang, J.A. Shields, W.R. Green (eds.), W.B. Saunders,

308, 1999.

15. Fekrat, S., Finkelstein, D.: Venous occlusive disease. In: Vitreoretinal Disease: The

Essentials, chapter 9. C.D. Regillo, G.C. Brown, H.W. Flynn, Jr. (eds.), Thieme Medical

Pub., 117-132, 1999.

16. Fekrat, S., Finkelstein, D.: Branch retinal vein occlusion. In: Retina. S.J. Ryan, R.

Murphy and A.P. Schachat (eds.), Third edition, Mosby, St. Louis (in press).


16

LETTERS TO THE EDITOR

1. Branch Vein Occlusion Study Group: Letter to the Editor. Branch vein occlusion study.

Invest. Ophthalmol. & Vis. Sci., 18: 1097, 1979.

2. Branch Vein Occlusion Study Group: Letter to the Editor. Argon laser photocoagulation

for macular edema in branch vein occlusion. Am. J. Ophthalmol., 99: 219, 1985.

3. Sunness, J.S., Massof, R.W., Johnson, M.A., Finkelstein, D., Fine, S.L.: Letter to the

Editor. Peripheral retinal function in age-related macular degeneration. Arch.

Ophthalmol., 103: 1631, 1985.

4. Finkelstein, D., Kimball, A.: Letter to the Editor. Rick factors of branch vein occlusion.

Arch. Ophthalmol., 104: 795, 1986.

5. Finkelstein, D., Clarkson, J., Goldberg, I., Kimball, A., Orth, D., Ryan, S., Trempe, C.:

Letter to the Editor. More information needed regarding neovascularization and vitreous

hemorrhage in branch vein occlusion. Arch. Ophthalmol., 105: 311-312, 1987.

6. Finkelstein, D.: Letter to the Editor. Defense of Animal Research. Am. J. Ophthalmol.,

112: 101, 1991.

7. Madreperla, S., Palmer, R., Massof, R., Finkelstein, D.: Letter to the Editor. Visual

acuity and field loss in retinitis pigmentosa. Arch. Ophthalmol., 109: 109, 1991.

8. Massof, R.W., Finkelstein, D.: Letter to the Editor. Vitamin A supplementation for

retinitis pigmentosa. Arch. Ophthalmol., 111: 1458-1459, 1993.

9. Fekrat, S., Goldberg, M.F., Finkelstein, D.: Letter to the Editor. Laser-induced

chorioretinal anastomosis and central retinal vein occlusion. Arch. Ophthalmol., 117: p.

140, 1999.


17

EDITORIALS

1. Finkelstein, D., Massof, R.W.: Editorial. Louise L. Sloan: Pioneer in clinical vision

research. Arch. Ophthalmol., 100: 1347, 1982.

2. Finkelstein, D.: Editorial. Oh, the times! Tabloids and other non-peer-reviewed

publications. Arch. Ophthalmol., 103: 1641-1642, 1985.

3. Massof, R.W., Finkelstein, D.: Editorial. Supplemental vitamin A retards loss of ERG

amplitude in retinitis pigmentosa. Arch. Ophthalmol., 111: 751-754, 1993.

4. Finkelstein, D., Clarkson, J.G.: Editorial. Retinal vessel bypass: A promising new

clinical investigative procedure. Arch. Ophthalmol., 113: 421-422, 1995.

5. Finkelstein, D., Clarkson, J.G.: Editorial. Puenteo de los vasos retinianos. Un

procedimiento clinico investigativo nuevo y prometedor. Arch. Ophthalmol., (ED.ESP.)

6: 281-282, 1995.


18

ABSTRACTS

1. Brem, S., Finkelstein, D., Chen, C., Brem, H., Folkman, J., Patz, A.: Retinal

neovascularization: experimental induction by intravitreal tumor. Invest. Ophthalmol. &

Vis. Sci., Suppl., 1975.

2. Finkelstein, D., Brem, S., Chen, C., Folkman, J., Patz, A.: Retinal neovascularization:

effect of intravitreal tumors on retinal vessels. Invest. Ophthalmol. & Vis. Sci., Suppl.,

1976.

3. Finkelstein, D., Patz, A., Folkman, J., Kingsley, R., Miller, S., Sternberg, P.:

Experimental retinal neovascularization. Invest. Ophthalmol. & Vis. Sci., Suppl., 1977.

4. Massof, R.W., Finkelstein, D., Fleischman, J., Maumenee, I.H., Kenyon, K.R.: Foveal

vision abnormalities in retinitis pigmentosa. Invest. Ophthalmol. & Vis. Sci., Suppl.,

1977.

5. Clarkson, J., Diddie, K., Finkelstein, D., Orth, D., Trempe, C.: Branch vein occlusion:

the development of a multi-center randomized clinical trial. Invest. Ophthalmol. & Vis.

Sci., Suppl., 1978.

6. Massof, R.W., Finkelstein, D.: Rod sensitivity relative to cone sensitivity in retinitis

pigmentosa. Invest. Ophthalmol. & Vis. Sci., Suppl., 1978.

7. Finkelstein, D., Patz, A., Fine, S.L.: Branch vein occlusion: development of

neovascularization. Invest. Ophthalmol. & Vis. Sci., Suppl., 1979.

8. Massof, R.W., Finkelstein, D., Starr, S.J., Fitzke, F.W.: Subcategories of primary retinitis


9. Palmer, R.W., Massof, R.W., Finkelstein, D.: Heterogeneity within subgroups of retinitis


10. Massof, R.W., Fitzke, F.W., Finkelstein, D.: Foveal temporal resolution in retinitis

pigmentosa. Invest. Ophthalmol., & Vis. Sci., Suppl., 1980.

11. Johnson, M.A., Massof, R.W., Finkelstein, D.: Peripheral absolute threshold spectral

sensitivity in retinitis pigmentosa. Invest. Ophthalmol. & Vis. Sci., Suppl., 1980.

12. Reissig, M., Finkelstein, D., Kashima, H., Massof, R.W., Hillis, A., Proctor, D.: Nasal

cilia in retinitis pigmentosa. Invest. Ophthalmol. & Vis. Sci., Suppl., 20: p. 41, 1981.

13. Massof, R.W., Wu, L., Finkelstein, D., Perry, C., Starr, S.J., Fitzke, F.W., Johnson, M.A.:

Properties of the electroretinogram in retinitis pigmentosa. Invest. Ophthalmol. & Vis.

Sci., Suppl., 20: p. 121, 1981.


19

14. Sternberg, P., Fitzke, F.W., Finkelstein, D.: Cyclic macular edema. Invest. Ophthalmol.,

& Vis. Sci., Suppl., 22: p. 8, 1982.

15. Massof, R.W., Finkelstein, D.: A possible non-genetic form of retinitis pigmentosa.

Invest. Ophthalmol. & Vis. Sci., Suppl., 22: p. 138, 1982.

16. Finkelstein, D., Diddie, K., Hillis, A., Kimball, A., Orth, D., Trempe, C., Clarkson, J.:

Branch vein occlusion: neovascularization outside the involved segment. Invest.

Ophthalmol. & Vis. Sci., Suppl., 22: p. 195, 1982.

17. Lindsey, P., Finkelstein, D., D’Anna, S.: Experimental foveal relocation. Invest.

Ophthalmol. &Vis. Sci., Suppl., 24: p. 242, 1983.

18. Massof, R.W., Benzschawel, T., Palmer, R., Finkelstein, D.: Natural course of visual

sensitivity loss in simplex and multiplex retinitis pigmentosa. Invest. Ophthalmol. & Vis.

Sci., Suppl., 24: p. 292, 1983.

19. Johnson, M.A., Finkelstein, D., Massof, R.W.: Retinal function in branch vein occlusion.


20. The Branch Vein Occlusion Study Group: “Progressing” branch vein occlusion. Invest.


21. Patel, A., Michels, R.G., Finkelstein, D.: BVO neovascularization: status following

vitrectomy. Invest. Ophthalmol. & Vis. Sci., Suppl., 25: p. 252, 1984.

22. Massof, R.W., Benzschawel, T., Emmel, T., Palmer, R., Finkelstein, D.: The spread of

retinal degeneration in retinitis pigmentosa. Invest. Ophthalmol. & Vis. Sci., Suppl., 25:

p. 196, 1984.

23. Stevens, R.A., Finkelstein, D.: Retinal pigment epithelial removal; an experimental

model. Invest. Ophthalmol. & Vis. Sci., Suppl., 25: p. 256, 1984.

24. Sunness, J.S., Massof, R.W., Johnson, M.A., Finkelstein, D., Fine, S.L.: Age-related

macular degeneration and peripheral retinal function. Invest. Ophthalmol. & Vis. Sci.,

Suppl., 26: p. 58, 1985.

25. Massof, R.W., Sunness, J.S., Palmer, R., Emmel, T., Finkelstein, D.: Unilateral and

asymmetric retinitis pigmentosa: characteristics and natural history. Invest. Ophthalmol.

& Vis. Sci., Suppl., 26: p. 128, 1985.

26. Johnson, M.A., Finkelstein, D.: The electroretinogram in retinal vein occlusion. Invest.


27. Johnson, M.A., Finkelstein, D.: Neovascularization and retinal sensitivity loss in patients

with retinal ischemia. Invest. Ophthalmol. & Vis. Sci., Suppl., 27: p. 145, 1986.


20

28. Finkelstein, D., Patz, A.: Presumed RPE change secondary to cystoid macular edema.


29. El Baba, F., Green , W.E., Fleischmann, J., Finkelstein, D., De la Cruz, Z.C.: Lipidization

and detachment of the RPE. Invest. Ophthalmol. & Vis. Sci., Suppl., 27: p. 319, 1986.

30. Choy, D., Massof, R., Finkelstein, D.: Normal visual fields in retinitis pigmentosa.


31. McPhee, T., Johnson, M., Massof, R.W., Finkelstein,D.: ERG after fundus photography

and fluorescein angiography. Invest. Ophthalmol. & Vis. Sci., Suppl., 28: p. 236, 1987.

32. Wilson, D.J., Finkelstein, D., Quigley, H.A., Green, W.R.: “Grid” macular

photocoagulation: A quantitative histologic study of the effect on the primate retinal

capillaries. Invest. Ophthalmol. & Vis. Sci., Suppl., 28: p. 320, 1987.

33. Finkelstein, D., Massof, R.W., Palmer, R.W.: Retinitis pigmentosa: Design of a pilot

laser clinical trial in progress. Invest. Ophthalmol. & Vis. Sci., Suppl., 29: p. 142, 1988.

34. Finkelstein, D., Bressler, N., Sunness, J., Yarrian, D.: Good visual acuity following

pigment epithelial rip through the fovea. Invest. Ophthalmol. & Vis. Sci., Suppl., 31: p.

48, 1990.

35. Madreperla, S., Palmer, R., Massof, R., Finkelstein, D.: Visual acuity in retinitis

pigmentosa. Invest. Ophthalmol. & Vis. Sci., Suppl., 31: p. 498, 1990.

36. Finkelstein, D.: Ischemic macular edema. Invest. Ophthalmol. & Vis. Sci., Suppl., 33: p.

805, 1992.

37. Schneider, T.L., Finkelstein, D., Malouf, A., Kaplan, G.: Bilateral rubeosis iridis in a 36

year-old male as the presenting sign of obesity-hypoventilation syndrome: implication for

angiogenesis. Invest. Ophthalmol. & Vis. Sci., Suppl., 34: p. 841, 1993.

38. Dagnelie, G., Sunness, J., Palmer, R.W., Finkelstein, D., Massof, R.W.: Unilateral and

asymmetric retinitis pigmentosa: incidence and long-term follow-up. Invest. Ophthalmol.

& Vis. Sci., Suppl., 34: p. 1368, 1993.

39. Finkelstein, D., for the Central Vein Occlusion Study Group: Central vein occlusion

study: Design, baseline, and early natural history. Invest. Ophthalmol. & Vis. Sci.,

Suppl., 34: p. 1442, 1993.

40. Zeimer, R., Asrani, S., Zou, S., Goldberg, M., Finkelstein, D., Quigley, H., D’Anna, S.:

The retinamap: A method to evaluate retinal pathology and map the retinal thickness.

Invest. Ophthalmol. & Vis. Sci., Suppl., 1996.


21

41. Zeimer, R., Yang, Y.S., Vitale, S., Bressler, N.M., Finkelstein, D., Schachat, A.P.,

Nishiwaki, H., Blankenship, Jr., G.C.: Association between locations of focal laser

treatment for clinically significant macular edema and quantitatively assessed retinal

thickening. Invest. Ophthalmol. & Vis. Sci., Suppl., 1998.

42. Zou, S., Zeimer, R., Yang, Y.S., Vitale, S., Bressler, N.M., Finkelstein, D., Schachat,

A.P.: Quantitative assessment of reduction in retinal thickening after focal

photocoagulation for clinically significant macular edema. Invest. Ophthalmol. & Vis.

Sci., Suppl., 1998.


22

NON-PEER REVIEWED

1. Finkelstein D, Spiritual discussions: Patient values are key, Medical Ethics Advisor, Vol

28, No. 9, September 2012, p 104

curriculum vitae daniel finkelstein, m.d.€¦ · curriculum vitae daniel finkelstein, m.d....

Documents